Posted by AGORACOM-JC
at 1:50 PM on Wednesday, April 10th, 2019
Announced that further to the letter of intent entered into a funding and profit sharing agreement with Worm Castings Farms Inc.,
Continuing to work with Worm Castings regarding its Hemp assets and is close to finalizing the Definitive Agreement with the principals of Worm Castings
VANCOUVER, British Columbia, April 10, 2019 – BOUGAINVILLE VENTURES INC. (CSE: BOG) (8BV–FF:Frankfurt Stock Exchange) (the “Company“) would like to announce that further to the letter of intent (“LOIâ€) entered into a funding and profit sharing agreement with Worm Castings Farms Inc., (“Worm Castingsâ€), announced October 29, 2018, the Company is continuing to work with Worm Castings regarding its Hemp assets and is close to finalizing the Definitive Agreement with the principals of Worm Castings. Worm Castings is the sole owner of an Oregon State Hemp production and processing license, issued by the Oregon State Regulatory approval board. Upon finalization of the transaction Worm Castings will be considering a name change from Worm Castings Farms Inc., to a name that better reflects its Hemp production and CBD processing objectives. In addition,Worm Castings is exploring other Hemp and CBD production and processing related opportunities.
President & CEO, Andy Jagpal Comments:
“The Farm Bill, which went into effect on January 1, 2019, is a
monumental step for the hemp industry, and is a historic event which
will create a tremendous amount of opportunities for Hemp farmers, like
Worm Castings, whose goal is to produce a Cannabidiol (CBD) product used
to treat various ailments and improve wellbeing.“
The Company would also like to announce that, in the name of
transparency, until the company is profitable management salaries will
be capped at $5,000 per month for each of the two operating directors on
an accrued basis. In addition, there is a stock option plan for
management and administration which will be 1,950,000 shares with a
strike price of 25 cents.
Bougainville’s issued and outstanding share figure on the CSE profile
has been updated to 58,625,424 to reflect the changes announced in the
news release disseminated April 8, 2019 in which 18,125,000 shares were
cancelled. The company has issued 577,883 common shares and 492,883
common share warrants as securities for debt owed to consultants.
About Bougainville Ventures, Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.
Posted by AGORACOM-JC
at 10:16 AM on Wednesday, April 10th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Cannabis Infused Food Is the Hottest Trend Currently
Three in four cooks stated that CBD- and hashish-infused meals could be a scorching development this year.
By Richard King
The FDA will not approve of this year’s
hot meals pattern. The National Restaurant Association and the American
Culinary Federation surveyed 650 skilled cooks concerning the original
culinary and restaurant ideas for 2019. Three in four cooks stated that
CBD- and hashish-infused meals could be a scorching development this
year.
Cooks’ curiosity in hashish and CBD, a
non-psychoactive compound discovered within the hashish plant, doesn’t
essentially imply that it’s coming to eating places anytime quickly.
Hashish stays unlawful on the general
degree, and solely 10 states have legalized it for leisure functions.
Some restaurateurs seeking to get in on the pattern with somewhat less
scrutiny have turned to personal supper golf equipment that supplies
menus with upscale hashish-infused dishes.
That’s true in Canada too; the place
edibles received’t are authorized till October regardless of the
nation’s 2018 legalization of marijuana.
Chef Travis Petersen travels throughout
Canada internet hosting hashish-infused dinners at Airbnb leases. To
remain comparatively underneath the radar, he advertises his dinners on
social media. A lot of his diners are “canna-curious†and barely nervous
about hashish-infused meals, so, for now, he sticks to utilizing
odorless, tasteless hashish oil.
Rich shoppers in states like Colorado
and Washington — the place the drug is authorized for leisure use – have
additionally turned to personal cooks who focus on cannabis-infused
meals, in accordance with Donna Hood Crecca, a principal at Technomic.
In the meantime, most CBD merchandise is
federally authorized after President Donald Trump signed the farm
invoice again in December. Nonetheless, the Food and Drug Administration
prohibits including CBD to meals and drinks as a result of it’s an
energetic ingredient in an FDA-authorized drug. The regulator has set
its first public hearing on legalizing CBD in food and drinks for May
31.
That hasn’t stopped some eating places
from promoting CBD-infused merchandise to reply to client demand. CBD,
brief for cannabidiol, is pitched as serving to the physique loosen up
without altering the thoughts like THC.
Tags: CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – #Cannabis Infused Food Is the Hottest Trend Currently $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 5:13 PM on Tuesday, April 9th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch
In 2018, legal cannabis spending grew by 65 percent to $569 million.
Through legalizing adult-use cannabis, Canada created a market that covers nearly 30 million consumers.
On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.
Yet the rollout of legal Canadian cannabis was fraught with shortages, a limited retail presence and poor product selection.
In 2018, legal cannabis spending grew by 65 percent to $569 million.
In the last two and a half months of 2018, adult-use sales reached
$112.5 million, falling short of estimates.
Canadian spending on medical marijuana alone in 2017 grew by 84 percent to $330 million.
In a fairly short period of time, Canada has become the home to cannabis companies like Aurora Cannabis Inc.ACB 2.38%, Canopy Growth CorpCGC 2.17%, Tilray Inc.TLRY 0.56%, Cronos Group, Inc.CRON 0.8% that have risen to become the largest cannabis companies in capitalization terms.
These firms are expanding their presence not just in Canada, but in other countries, either through exports or by establishing full-scale cultivation
and distribution operations. No matter what occurs in the Canadian
cannabis market, these companies have already established themselves as
global leaders.
Provincial Rules, Regulations Are Key
Through legalizing adult-use cannabis, Canada created a market that covers nearly 30 million consumers.
Shortages weren’t completely unexpected, given that the medical market had only included around 360,000 people.
The Canadian government allowed provinces to figure out how to deal with the legalization and consumption of cannabis.
Stricter rules in some provinces mean that overall cannabis spending
might be affected, with more consumers continuing to access the illicit
market and its lower prices.
In a new report, Arcview Market Research and BDS Analytics
project the legal cannabis market in Canada could reach $5.2 billion by
2024, with the bulk of the figure representing adult-use sales ($4.8
billion).
Arcview and BDS Analytics issued a province-by-province breakdown, to
show that not only the role the population plays in the cannabis
market’s size, but how regulations and the environment created by local
government should also be taken into account.
Four Key Provinces
Arcview and BDS identified four main provinces that they project will
dominate the market in spending in 2024: Ontario, Alberta, Quebec and
British Columbia. These provinces will account for 85 percent of the
market by 2024 versus around 82 percent in 2018, according to the
report.
While Ontario is the largest market due to its high population and
favorable business environment, Alberta is the second-largest, despite
having the lowest population of the four provinces, the research firms
said.
Quebec is the second-largest province in terms of population, but
ranks fourth in terms of market share. This figure is not only due to
regulations, but also due to very low number of consumers.
Let’s take a closer look at how the cannabis market is projected to
develop in each of these four provinces and the main factors affecting
that growth.
Ontario
Ontario is Canada’s most populous province, with 14.4 million people.
At the same time, 26 percent of the population identifies themselves as
cannabis consumers and 31 percent as acceptors, or people who would
consider consuming in the future, according to BDS Analytics’ Consumer
Insights. The Ontario cannabis market is expected to exceed $2 billion,
with adult-use consumption accounting for $1.8 billion.
The province also has some of the more permissive rules regarding
cannabis consumption. Smoking and vaping is allowed in public areas like
parks and at designated rooms at hotels, motels and inns. Other than
those provisions, public use is regulated in the same way as tobacco.
Another major factor that will help Ontario’s cannabis market growth:
changes at the retail level. The government-run Ontario Cannabis Store
is being replaced with private retailers, and officials have not set a
cap on licenses, although they estimate between 500 and 1,000 locations
will eventually open across the province.
Alberta
Alberta is Canada’s fourth-most populous province, with around 4.3
million people in 2018. Since legalization and through the end of 2018,
the province registered 28 percent of the total cannabis sales in the
country.
The province has a higher-than-average number of consumers (27 percent) and acceptors (32 percent), BDS and Arcview said.
In Alberta, adult-use cannabis is available to people above 18 years of age versus 19 years in Ontario and British Columbia.
The main factor helping Alberta’s cannabis market is the favorable
business environment. Following legalization, regulators in Alberta
quickly allowed private retailers to enter the market. Two hundred
adult-use stores are expected in Alberta, compared to an average of 50
stores in other provinces.
Quebec
Quebec is expected to represent less than 14 percent of the Canadian cannabis market in 2024.
Even though it’s the second-largest province in terms of population,
only 20 percent of residents are consumers and it is home to just 3
percent of registered medical patients. Quebec is reportedly considering
raising the legal age of consumption fro 18 to 21. Total cannabis
spending is expected to reach $704 million in 2024.
Even though its population is much smaller than Quebec’s —5 million
vs. 8.3 million — British Columbia is projected to amass 14% of total
Canadian cannabis spending in 2024, slightly more than in Quebec. Legal
sales are expected to reach $722 million by 2024.
Retail sales in British Columbia are conducted both through
province-run and private stores. Earlier this year, the British Columbia
Liquor Distribution Branch, which is the sole wholesale distributor of
non-medical cannabis, partnered with 31 large licensed producers,
including Canopy Growth, which operates the largest cannabis greenhouse
in the world in the province.
What To Keep In Mind
While provincial regulations may slow down cannabis market growth in
Canada, it’s still poised to grow at at an impressive rate, as more
products become available sometime later this year and more retailers
are allowed to set up locations across provinces.
In the meantime, the legalization of adult-use cannabis in Canada and
a regulatory system that gives some degree of leeway to provinces or
even municipalities are providing a case study to the rest of the world
to see which approaches work best at ensuring safety and quality — and
which should be avoided.
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 4:26 PM on Thursday, April 4th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year as shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
NORTHBUD Signs Binding Letter of Intent to Enter U.S. Market
with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor
CHECK OUT OUR RECENT INTERVIEW
FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 10:53 AM on Tuesday, April 2nd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Edible Arrangements: The Global Cannabis Edibles Market
The global cannabis edibles market is one of the most promising segments of the overall industry, presenting a world of opportunity for cannabis edibles companies to set themselves apart with unique and appealing products.
For cannabis connoisseurs, cannabis edibles have always been an alluring proposition.
For cannabis connoisseurs, cannabis
edibles have always been an alluring proposition. Take something you
already enjoy, and add it to something delicious. What’s not to like?
The classic “special brownie†and the famous “space cakes†that have
been enjoyed at Amsterdam coffee shops for decades are only just the tip
of the edibles iceberg. Today, cannabis
is being added to candy, artisanal baked goods, coffee, jerky, pizza,
upscale cuisine and so much more, meaning the possibilities are endless
for the global cannabis edibles market.
It’s no surprise that the Canadian
legal cannabis industry is hungrily eyeing cannabis edibles as they
promise to account for a huge portion of the overall cannabis market as
soon as Health Canada allows it. In the meantime, however, this highly
promising market segment faces some significant regulatory challenges.
That won’t stop companies from taking an interest in edibles, as they
already make up a huge portion of the market in legal jurisdictions
where they are allowed, such as California and Nevada.
Edibles to take cannabis market by storm
The consumer appeal of edibles is
obvious. The sheer amount of variability creates countless possibilities
for cannabis companies looking to make their products stand out.
Edibles can be tailored to any type of cannabis consumer, from high-end
dark chocolates served at posh dinner parties to gummy candies enjoyed
before a rock concert. It’s easy to make edible cannabis products eye
catching and appealing. For newcomers trying cannabis for the first time
after legalization, edibles may provide a less intimidating entry point
than smoking or vaping. And medical users often appreciate the stronger
and longer-lasting effect of orally ingested cannabis.
An October 2018 report
by ArcView Market Research and BDS Analytics projects the North
American cannabis edibles market to hit more than $4.1 billion by 2022.
According to the report, food and drink products accounted for
approximately 11.4 percent of total cannabis spending in Canada and the
United States in 2017. As the cannabis market matures and develops, and
as edible products return to dispensary shelves in Canada, classic dried
cannabis flower is expected to steadily lose market share to edibles
and extracts.
Regulatory challenges and solutions
Right now in Canada, though, the more
immediate future of the cannabis edibles market is less certain.
Edibles were not included in the first wave of cannabis legalization
that took place in October 2018, with Health Canada opting to conduct
further study and consultation before rolling out regulatory rules by
October 2019. This put a wrench in the gears for the hundreds of
cannabis companies that had made edibles a key part of their initial
business strategy. In early 2019, Health Canada began a two-month public
consultation period as part of the process of determining the edibles
regulatory scheme. By all accounts, the restrictions are likely to be
heavy. Chief among the rules will be restrictions on potency and
mandates on accurate potency labeling.
The concerns over potency and
accurate labeling aren’t entirely unwarranted. Cannabis edibles have
always been tricky in the way they hit the user. Cannabis ingested
through the digestive system can take an hour or more to for the user to
notice the effect, and inexperienced users have commonly been known to
make the rookie mistake of taking more under the belief that they
haven’t taken a high enough dosage. Due to the intense nature of edible
products, the appeal of edibles to inexperienced cannabis users in
particular can be a recipe for disaster. Excessive dosage of cannabis is
not highly dangerous in that it will not cause poisoning or other
health emergencies, but cannabis-related panic attacks can still present
a risk.
This is why cannabis companies that
plan on making edibles a significant part of their business model have
dedicated considerable resources to developing precision dosing
technology. The challenge stems from the fact that the rate in which
cannabis breaks down as it enters the bloodstream varies significantly
based on a number of factors, including the specific physiology of the
consumer.
Recent years have seen the development of tools
for manipulating cannabis at the molecular level for greater
bioavailability, allowing edibles manufacturers to provide a more
predictable product for easier regulatory compliance and greater
consumer trust.
Regulators have been placing a range
of other regulatory hurdles in the way of the edibles market. Health
Canada is expected to enforce tight restrictions on edibles packaging,
limiting the use of colorful graphics and other eye-catching elements
largely with the intent of limiting the products’ appeal to children.
Packaging will also need to be child resistant. Regulators in various
jurisdictions have often restricted potency, with Health Canada expected
to limit products to 10 milligrams of THC per dose. Similarly,
California has focused its regulations around keeping cannabis edibles
out of the hands of children with a universal cannabis product symbol, a
government warning, child-proof packaging and clear labeling for
potency and recommended dosage.
Takeaway
Not every cannabis consumer is
particularly interested in smoking or vaping, but everyone is interested
in tasty treats. Meeting regulatory hurdles for dosing and keeping
products out of the hands of children has been a challenge, but these
challenges hardly reduce the potential of what promises to be, and in
many jurisdictions already is, one of the primary market segments of the
cannabis industry.
Posted by AGORACOM-JC
at 4:29 PM on Monday, April 1st, 2019
Announced that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant starting June 01, 2019.
Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board to begin planting the Tenant’s crop for the season.
In addition to the 10,000 sq. ft. space, Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.
VANCOUVER, British Columbia, April 01, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG), providing cannabis infrastructure and seed-to-sale services to I-502 tenant-growers, is pleased to announce that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant (the “Tenantâ€) starting June 01, 2019. The Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board (WSLCB) to begin planting the Tenant’s crop for the season. In addition to the 10,000 sq. ft. space the Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.
CEO, Andy Jagpal Comments: “We are excited to
see our first Tier-3, I-502 tenant move forward towards a successful
growing season. This first planting season signals a new phase for
Bougainville concept of providing fully built out turnkey facilities to
cannabis growers and processors.These facilities remove financial
barriers for cannabis cultivators as traditional funding can be limited.
In addition, steps are being taken to get a second tenant up and
running for the 2019 growing season. We are moving towards our goal of
revenue generating self-sufficiency.â€
About the Washington I-502 Marijuana Market In November 2012, the Washington State Liquor Control Board (WSLCB) passed Initiative 502 (I-502) pursuant to a vote by the people of the State of Washington. I-502 authorized the WSLCB to regulate and tax recreational marijuana products for persons over twenty-one years of age and thereby created a new industry for growing, processing and selling of Washington State-regulated recreational marijuana products. A recent WSLCB commissioned report by the Rand organization suggests that there are currently up to 650,000 recreational marijuana users in Washington State, worth approximately $1.25 – $1.5 billion USD in annual sales.Â
About Bougainville Ventures, Inc. Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost. Bougainville has 10,000 sq.ft., in near production in Oroville, WA, sufficient land for two more pods of the same size.
Posted by AGORACOM-JC
at 8:06 AM on Wednesday, March 20th, 2019
Announced that MCOA has entered into a letter of intent (LOI) with Natural Plant Extract of California (NPE) and its subsidiary, Northern Lights Distribution, LLC (NLD),
To acquire a 20% ownership interest in NPE, and to establish a Joint Venture (JV) to operate a California cannabis delivery service named Viva Buds.
ESCONDIDO, Calif., March 20, 2019 — via NetworkWire — MARIJUANA COMPANY OF AMERICA INC.(“MCOA†or the “Companyâ€) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that MCOA has entered into a letter of intent (LOI) with Natural Plant Extract of California (NPE) and its subsidiary, Northern Lights Distribution, LLC (NLD), to acquire a 20% ownership interest in NPE, and to establish a Joint Venture (JV) to operate a California cannabis delivery service named Viva Buds.
Under the terms of the LOI, MCOA has committed to contribute
$2,000,000 in total cash to the project, as well as common shares of the
Company with a value of $1,000,000. In exchange, MCOA will own a 20%
equity position in NPE. In addition, both NPE and MCOA will form a JV to
operate Viva Buds and will share in the profits on a 50/50 basis.
NPE has obtained both state and city licenses for volatile
manufacturing, distribution and retail delivery of cannabis products.
NPE has a long-term lease with favorable terms for its location at 11116
Wright Road, Lynwood, CA. NPE will manage all operations pertaining to
distribution, manufacturing, and delivery of cannabis products, and MCOA
will provide capital, consulting and marketing services. NPE is
currently generating revenue through its distribution business segment
under NLD, which it launched in 2018 and is undergoing construction of
its manufacturing lab since it recently obtained all of the necessary
state and local permits.
As part of the JV with NPE’s distribution company NLD, MCOA formed a
wholly owned subsidiary called Viva Buds Inc. to serve as the marketing
arm for NLD’s new retail delivery service in California. The Company
will initially focus on delivering cannabis products to Southern
California and then rollout to other cities statewide. NLD will
contribute up to $300,000 in inventory of cannabis products to assist in
the start-up of this venture and will oversee all delivery and
fulfillment of orders. MCOA will provide a vast array of marketing
services and technology to promote and build its Viva Buds brand.
The parties are in the process of conducting due diligence and completing a material definitive agreement.
Donald Steinberg, CEO of MCOA stated, “This partnership will enable
MCOA to establish itself as a major player in the Cannabis arena. All
licenses are in place to allow for vertical integration from farm to
consumer. We are excited to expand our business model to now include
marketing our new THC brand Viva Buds through our fully licensed partner
NPE. The NPE team has a great deal of industry knowledge and has an
industry disruptive business model. This is a huge strategic move for
MCOA!â€
Alan Tsai, NPE’s CEO stated, “We are excited to become partners with
MCOA as it will help us to finalize the development of our manufacturing
plant faster than planned. We are aggressively focused on maximizing
our market share by securing distribution, manufacturing and co-packing
contracts with reputable brands throughout California. We believe that
this is a crucial year for expansion in the cannabis industry in
California and it’s our goal to position our company as a key player in
the industry in multiple verticals.â€
About Natural Plant Extracts of California NPE
is a fully licensed cannabis manufacturing, distribution and non-store
front retail delivery. The Company has secured its licenses with the
state of California and city of Lynwood, CA. For more information about
the Company, please visit its website at https://nldistribution.com
The owners and founders of NPE are marijuana industry veterans with
decades of experience in establishing retail, manufacturing and
distribution of cannabis in California, including obtaining the first
retail dispensary licenses in Los Angeles, CA.
About Marijuana Company of America, Inc. MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward Looking Statements This
news release contains “forward-looking statements” which are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate”,
“seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or
similar phrases may be deemed “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
For more information, please visit the Company’s websites at:
Posted by AGORACOM-JC
at 8:14 AM on Tuesday, March 19th, 2019
Empower in partnership with Canntop AI has commenced preliminary testing and analysis to identify key insights for improvements to physician recommended treatment plans
Company has provided select SEO terms and phrases for use in Canntop’s artificial intelligence platform, targeting two key company markets, Portland, OR and Phoenix, AZ,
VANCOUVER, March 19, 2019 – EMPOWERCLINICS INC. (CSE: EPW) (Frankfurt: 8EC) (“Empower” or the “Company“), a growth oriented and diversified medical cannabis company, is pleased to provide an update on recent activities by the technical teams at Empower and Canntop AI Inc. (“Canntop“), a subsidiary of Datametrex AI Limited (“Datametrex“) to develop a deeper understanding of patient awareness of cannabis-based treatment options and ongoing effectiveness of treatment programs.
The Company has provided select SEO terms and phrases for use in Canntop’s artificial intelligence (“AI“) platform, targeting two key company markets, Portland, OR and Phoenix, AZ,
to gain actionable insights on how consumer social data is generating
interest in CBD-based products, alternative pain management options and
the use of cannabis-based therapies.
“Insights derived from AI are beginning to demonstrate how patients
in our key markets are talking about or describing their experience and
ideas related to cannabis/CBD-based treatments, and even suggesting
recommendations about alternative therapies and their effectiveness in
treating a wide array of qualifying conditions,” stated Steven McAuley, Empower’s Chief Executive Officer.
“We believe the outcomes of our AI efforts, if successful, could
position the Company as an educational leader and we plan to collaborate
with the industry with the ultimate goal of improving patient care,”
said Mr. McAuley. “Canntop’s powerful AI tools are helping us analyze
the substantial amounts of data in the Empower database and we expect
will facilitate the integration of the additional data we expect to
derive from the proposed acquisition of the Sun Valley Clinic group,
that has a combined 165,000 patients.”
“We are thrilled that Empower chose Canntop AI to be their partner
for their Artificial Intelligence needs. This is a great validation for
our business model and we look forward to expanding our program with
Empower as they continue to expand their product. We believe that this
alliance between Canntop and Empower will create a strong platform for
data analysis in the cannabis sector especially in the U.S., providing
insurers and health care providers an ideal solution for patient care,”
said Michael Frank, Chief Strategy Officer of Datametrex.
EMPOWER TECHNOLOGY
Patient EHR and Management System Empower utilizes a
market-leading patient electronic management and POS system that is
HIPAA compliant and provides deep insight to patient care.
Tele-Medicine Platform The Company supports remote
patients using its tele-medicine portal, enabling patients who do not
live near one of its clinic locations, or are disabled or unable to come
to a location, to still benefit from a doctor consultation.
Website and e-commerce Empower will be commencing the
development of its new corporate website and e-commerce store to promote
and sell its growing line of CBD-based products under the Sollievo
brand and other partner brands.
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative uses of medical cannabis. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure
to Artificial Intelligence and Machine Learning through its wholly owned
subsidiary, Nexalogy (www.nexalogy.com) and Implementing Blockchain technology for secure Data Transfers through its investee company, Graph Blockchain (www.graphblockchain.com).
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding: the proposed acquisition of Sun Valley;
the expected benefits to be derived from use of the Canntop AI tools;
the ability of Canntop’s software to assist in integrating Sun Valley
data (assuming the successful completion of such transaction); the
benefits of CBD based products; and that the Company will be positioned
to be a market-leading service provider for complex patient requirements
in 2019 and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including: that the Canntop software may not
be able to properly analyze the Company’s information as is expected or
at all; that the proposed acquisition of Sun Valley may
not be completed on the terms expected or at all; that regulatory
proceedings may negatively impact the Company’s business; that
legislative changes may have an adverse effect on the Company’s business
and product development; that the Company may not be able to obtain
adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146Copyright CNW Group 2019
Posted by AGORACOM-JC
at 9:00 PM on Sunday, March 17th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
The marijuana industry looks like the fastest-growing job market in the U.S
The marijuana industry added 64,389 jobs in 2018, a 44 percent gain, according to industry experts Leafly and Whitney Economics.
Economists believe the U.S. job market overall is getting tight, evidenced by the 20,000 growth in payrolls for February
Job creation is expected to grow as more states legalize pot. Nick Colas at DataTrek Research said cannabis is the “fastest-growing labor market in the U.S.”
Published 19 Hours Ago Updated 17 Hours Ago CNBC.com
Tom Franck | CNBC
Canopy Growth operations in Smiths Falls, Ontario.
At a time when the rest of the labor market appears to be tightening
up, the marijuana industry is just getting started when it comes to job
creation, according to a recent report.
Pot manufacturers and distributors, on both the recreational and
medicinal sides, saw massive job creation in 2018, with 64,389 new
positions added to the rolls. That brings to 211,000 the number of jobs
directly related to the industry, part of a total of 296,000 in all
related areas combined, industry site Leafly said in a report it compiled with Whitney Economics.
The U.S. economy in total created about 2.7 million new jobs in 2018,
according to the Bureau of Labor Statistics, which does not count
cannabis-related hiring because the substance is still considered a
Schedule 1 narcotic at the federal level.
Hiring slowed to a crawl in February, with payrolls growing by just 20,000.
That came even though the BLS said there were 7.3 million job openings
against just 6.3 million considered unemployed in December, the most
recent month for which data were available.
Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry 8:56 AM ET Wed, 13 March 2019 | 05:34
“Amid the roiling debate over American jobs, the legal cannabis
industry remains a substantial and unrecognized engine of grassroots job
creation,” the report’s authors wrote. “In 2019, America’s cannabis
industry is one of the nation’s greatest economic success stories. That
success deserves to be recognized and celebrated.”
The document was written by Bruce Barcott, Leafly’s deputy editor, and Whitney Economics founder Beau Whitney.
Because there is no official count the report had to use some
unconventional methods to estimate the jobs total. They utilized state
data, industry surveys, information from operators, proprietary data and
other economic formulas.
What they found was stunning: a 44 percent gain in the workforce for
2018 that came on top of a 21 percent increase the previous year.
At 211,000, the total number of jobs compares favorably to other more
mainstream occupations: there were 131,430 chefs in the country, for
instance, along with 65,760 aerospace engineers and 40,000 computer
operators, according to the most recent BLS counts.
“US marijuana legalization is a rare example of disruption creating
jobs rather than destroying them,” Nick Colas, co-founder of DataTrek
Research, said in a note Thursday that highlighted some of the cannabis
jobs data. “With the US labor market recently showing signs of weakness
and fears of an eventual recession in the wings, this is one industry
that might soften the blow of an economic downturn.”
Colas expects pot-related job creation to continue as more states
legalize the substance. He called cannabis “the fastest-growing labor
market in the U.S.”
Along with the bottom-line gains, the industry’s growth also offers
an alternative to the push for young Americans to get a college degree,
which has led to an explosion of student loan debt that now totals
nearly $1.6 trillion.
“Americans with a college degree are basically at full employment,
but most Americans do not have those credentials and their participation
rates are lower than the former,” Colas wrote. “The marijuana industry
offers solid paying positions at all levels of experience and
educational attainment.”
Colas cited Glassdoor data showing that median pay in the cannabis
industry is 11 percent above the median U.S. salary of $52,863.
“Budtenders,” the staff members who work directly with customers,
generally earn $12 to $16 an hour, according to the site that allows
current and former employees to review their workplaces and list typical
salaries.
At the other end of the spectrum, cultivation and extraction
directors and outside sales representatives can earn well into six
figures.
Tags: Marijuana, otc, tsx, tsx-v, weed Posted in All Recent Posts, Bougainville Ventures | Comments Off on Bougainville Ventures Inc $BOG.ca – The #marijuana industry looks like the fastest-growing job market in the U.S #weed $CROP.ca $VP.ca NF.ca $MCOA
